Reuters -- Generic forms of Pfizer Inc’s blockbuster Lipitor cholesterol fighter began flooding into Canada on Wednesday, in a taste of what is to come for the $12 billion-a-year drug next year in the United States.
Reuters -- Generic forms of Pfizer Inc’s blockbuster Lipitor cholesterol fighter began flooding into Canada on Wednesday, in a taste of what is to come for the $12 billion-a-year drug next year in the United States.